Hussman Strategic Advisors Inc. Has $2.30 Million Stake in Doximity, Inc. $DOCS

Hussman Strategic Advisors Inc. reduced its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 40.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 31,500 shares of the company’s stock after selling 21,000 shares during the quarter. Hussman Strategic Advisors Inc.’s holdings in Doximity were worth $2,304,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Root Financial Partners LLC bought a new position in Doximity during the third quarter worth $30,000. Hantz Financial Services Inc. lifted its stake in shares of Doximity by 148.9% during the 2nd quarter. Hantz Financial Services Inc. now owns 453 shares of the company’s stock worth $28,000 after buying an additional 271 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its stake in shares of Doximity by 59.5% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 480 shares of the company’s stock worth $35,000 after buying an additional 179 shares during the last quarter. Toth Financial Advisory Corp boosted its holdings in shares of Doximity by 150.0% during the 3rd quarter. Toth Financial Advisory Corp now owns 500 shares of the company’s stock worth $37,000 after buying an additional 300 shares during the period. Finally, First Horizon Corp acquired a new position in Doximity in the 3rd quarter valued at about $58,000. Institutional investors own 87.19% of the company’s stock.

Doximity Price Performance

Shares of NASDAQ DOCS opened at $38.95 on Wednesday. The business has a fifty day moving average price of $45.01 and a two-hundred day moving average price of $58.09. The stock has a market capitalization of $7.33 billion, a PE ratio of 38.95, a P/E/G ratio of 4.10 and a beta of 1.39. Doximity, Inc. has a fifty-two week low of $38.90 and a fifty-two week high of $85.21.

Doximity (NASDAQ:DOCS) last issued its quarterly earnings results on Thursday, November 6th. The company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period in the previous year, the company earned $0.30 EPS. The firm’s revenue for the quarter was up 23.2% compared to the same quarter last year. On average, equities analysts expect that Doximity, Inc. will post 0.99 EPS for the current year.

Insider Activity at Doximity

In other news, Director Kira Scherer Wampler sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $66.44, for a total transaction of $132,880.00. Following the completion of the sale, the director owned 19,839 shares of the company’s stock, valued at approximately $1,318,103.16. This represents a 9.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 31.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on DOCS. Evercore ISI restated an “outperform” rating on shares of Doximity in a research report on Thursday, January 8th. KeyCorp dropped their price target on Doximity from $75.00 to $60.00 and set an “overweight” rating for the company in a report on Thursday, January 8th. Wells Fargo & Company raised Doximity from an “equal weight” rating to an “overweight” rating and decreased their price objective for the company from $65.00 to $55.00 in a report on Tuesday, January 20th. Barclays assumed coverage on Doximity in a research report on Monday, December 8th. They set an “overweight” rating and a $63.00 price objective on the stock. Finally, Truist Financial set a $62.00 target price on shares of Doximity in a research report on Thursday, January 8th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $65.74.

Doximity Profile

Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”

The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.